Navarro-Ramirez R, Lang G, Moriguchi Y, Elowitz E, Corredor JAlfredo, Avila MJ, Gotfryd A, Alimi M, Gandevia L, Härtl R.
2017.
Are Locked Facets a Contraindication for Extreme Lateral Interbody Fusion? World Neurosurg. 100:607-618.
Singh H, Essayed WI, Jada A, Moussazadeh N, Dhandapani S, Rote S, Schwartz TH.
2017.
Contralateral supraorbital keyhole approach to medial optic nerve lesions: an anatomoclinical study.. J Neurosurg. 126(3):940-944.
Sonabend AM, Zacharia BE, Cloney MB, Sonabend A, Showers C, Ebiana V, Nazarian M, Swanson KR, Baldock A, Brem H et al..
2017.
Defining Glioblastoma Resectability Through the Wisdom of the Crowd: A Proof-of-Principle Study.. Neurosurgery. 80(4):590-601.
Essayed WI, Singh H, Lapadula G, Almodovar-Mercado GJ, Anand VK, Schwartz TH.
2017.
Endoscopic endonasal approach to the ventral brainstem: anatomical feasibility and surgical limitations.. J Neurosurg. 127(5):1139-1146.
Esquenazi Y, Essayed WI, Singh H, Mauer E, Ahmed M, Christos PJ, Schwartz TH.
2017.
Endoscopic Endonasal Versus Microscopic Transsphenoidal Surgery for Recurrent and/or Residual Pituitary Adenomas.. World Neurosurg. 101:186-195.
Esquenazi Y, Essayed WI, Singh H, Mauer E, Ahmed M, Christos PJ, Schwartz TH.
2017.
Endoscopic Endonasal Versus Microscopic Transsphenoidal Surgery for Recurrent and/or Residual Pituitary Adenomas.. World Neurosurg. 101:186-195.
Niethammer M, Tang CC, LeWitt PA, Rezai AR, Leehey MA, Ojemann SG, Flaherty AW, Eskandar EN, Kostyk SK, Sarkar A et al..
2017.
Long-term follow-up of a randomized AAV2- gene therapy trial for Parkinson's disease.. JCI Insight. 2(7):e90133.
Niethammer M, Tang CC, LeWitt PA, Rezai AR, Leehey MA, Ojemann SG, Flaherty AW, Eskandar EN, Kostyk SK, Sarkar A et al..
2017.
Long-term follow-up of a randomized AAV2- gene therapy trial for Parkinson's disease.. JCI Insight. 2(7):e90133.